Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
High-Throughput Screening Services Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The high-throughput screening services market has seen rapid expansion in recent years. It is projected to expand from $23.02 billion in 2025 to $25.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. This historical growth can be linked to factors such as the expansion of pharmaceutical R&D activities, the increasing utilization of combinatorial chemistry libraries, the adoption of automated liquid handling systems, a rising demand for rapid target identification, and the widespread availability of large compound libraries.
The high-throughput screening services market is projected to experience substantial growth over the coming years. It is anticipated to reach a valuation of $39.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2% during this period. This expansion is driven by several factors, including increased investments in precision drug discovery, a heightened emphasis on biologics and complex targets, the broadening scope of personalized medicine research, the expanding application of AI-assisted screening workflows, and a rise in the outsourcing of screening services to contract research organizations (CROs). Key developments observed during the forecast period encompass the increasing deployment of automated robotic screening platforms, a surging demand for ultra-high-throughput screening services, wider acceptance of cell-based and label-free assays, the growing integration of AI-driven data analysis in drug discovery, and a sharpened focus on accelerating hit-to-lead identification.
Get A Free Sample Report With In-Depth Market Insights:
High-Throughput Screening Services Market Development Factors: What’s Supporting Demand?
The rising occurrence of chronic and complex illnesses is anticipated to drive growth in the high-throughput screening services market. These conditions are long-lasting health issues that involve numerous biological pathways, persist for extended periods, and typically demand continuous management rather than short-term treatment. The increase in their prevalence is largely attributed to aging global populations, lifestyle-related risk factors, and enhanced disease detection, collectively escalating the burden on healthcare systems and stimulating demand for sophisticated therapeutic solutions. High-throughput screening (HTS) services support research into chronic and complex diseases by enabling the rapid and concurrent assessment of a vast number of compounds against biological targets. This ability accelerates early-stage drug discovery, enhances target identification, and facilitates the development of more effective therapies for multifactorial and long-term ailments. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 76.4% of adults in the United States, representing more than 194 million people—reported having at least one chronic condition in 2023, while 51.4% (around 131 million people) reported multiple chronic conditions. Consequently, the expanding prevalence of chronic and complex diseases is fueling the growth of the high-throughput screening services market.
High-Throughput Screening Services Market Segment Analysis And Revenue Potential
The high-throughput screening services market covered in this report is segmented –
1) By Products And Services: Instruments; Reagents And Kits; Services
2) By Technology: Ultra-high-throughput Screening; Cell-based Assays; Lab-on-a-chip; Label-free Technology
3) By Application: Target Identification; Primary Screening; Toxicology
4) By End User: Pharmaceutical And Biotechnology Firms; Academia And Research Institutes; Contract Research Organizations
Subsegments:
1) By Instruments: Automated Screening Systems; Liquid Handling Systems; Detection And Imaging Systems; Data Acquisition Systems
2) By Reagents And Kits: Assay Reagents; Screening Kits; Cell Based Reagents; Detection Reagents
3) By Services: Assay Development And Optimization Services; Primary Screening Services; Hit Confirmation And Validation; Data Analysis And Bioinformatics Support; Specialized Screens; Project Management And Reporting
High-Throughput Screening Services Market Transformation Trends: What Innovations Are Driving Change?
Leading enterprises within the high-throughput screening services market are emphasizing advancements in miniaturized and high-density assays, such as those offering ultra-high screening speed with up to 27 detection channels, to facilitate quicker, extensive multiparametric analysis and enhance drug discovery processes. This capability, ultra-high screening speed with up to 27 detection channels, denotes the capacity to swiftly evaluate numerous biological variables concurrently, thereby increasing data generation and operational effectiveness in high-throughput screening studies. As an illustration, in May 2024, Evotec SE, a drug discovery and development services firm based in Germany, unveiled extensive high-throughput screening services integrated into its early discovery platform. Evotec conducts substantial biochemical and cell-based HTS initiatives leveraging highly automated, miniaturized assay technologies and sophisticated data analytics. The organization supports pharmaceutical and biotechnology collaborators by promptly identifying successful compounds and refining lead selection, consequently accelerating initial-stage drug discovery programs.
High-Throughput Screening Services Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the high-throughput screening services market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Eurofins Scientific SE, Charles River Laboratories International Inc., Revvity Inc., Bio-Rad Laboratories Inc., Hamilton Company, Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Molecular Devices LLC, ShanghAI Medicilon Inc., Sygnature Discovery Limited, Selvita S.A., Cayman Chemical Company, Creative Bioarray Inc., Axxam S.p.A., Axcelead Inc., Creative Biolabs Inc., Enamine Ltd., Aurora Biomed Inc.
View The Full High-Throughput Screening Services Market Report:
High-Throughput Screening Services Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the high-throughput screening services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-throughput screening services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
